0 Комментарии
0 Поделились
612 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Biologics & Precision Oncology: Prescription Drugs Market Set for Steady 6.76% CAGR Through 2032Global Prescription Drugs Market Poised to Surpass USD 2,444.22 Billion by 2032 Driven by Biologics Innovation, Next-Generation Targeted Therapies, and Rising Chronic Disease Prevalence The global pharmaceutical and clinical healthcare landscape is undergoing an unprecedented therapeutic and structural transformation. Driven by rapid breakthroughs in molecular biology, targeted genomics,...0 Комментарии 0 Поделились 552 Просмотры 0 предпросмотр
-
Biologics Manuuring Market Growth, Driving Factors, Strategies, Trends, Forecast Analysis By Fact.MRRockville, Maryland — October 28, 2026 The global biologics manufacturing market is projected to reach USD 225.52 billion by 2036, increasing from USD 46.92 billion in 2026 at a compound annual growth rate (CAGR) of 17.0%, according to Fact.MR. The market is expected to create an incremental opportunity of USD 178.60 billion over the forecast period, highlighting the expanding commercial...0 Комментарии 0 Поделились 289 Просмотры 0 предпросмотр
-
Biologics Market Size, Share & Growth ReportGlobal Biologics Market Poised for Exponential Growth as Targeted Therapies, Precision Oncology, and Advanced Biomanufacturing Reshape Modern Medicine 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @ https://www.maximizemarketresearch.com/request-sample/37255/ The global pharmaceutical landscape is experiencing an unprecedented structural shift from conventional small-molecule synthetic chemical synthesis to highly...0 Комментарии 0 Поделились 585 Просмотры 0 предпросмотр
-
Cell-Free Biologics Market Forecast Highlights 8.3% CAGR Through 2036October 3, 2026 — The Cell-Free Biologics Market is projected to reach USD 1.16 billion by 2036, rising from USD 0.53 billion in 2026 at a CAGR of 8.3%, according to Fact.MR analysis. The market was valued at USD 0.49 billion in 2025, with an absolute dollar opportunity of USD 0.63 billion expected between 2026 and 2036. The market is expanding through early-stage commercial adoption...0 Комментарии 0 Поделились 518 Просмотры 0 предпросмотр
-
Inflammatory Bowel Disease Biologics Market to Approach USD 130.8 Billion by 2036, India - CAGR 10.1%, China - CAGR 9.9%, Germany - CAGR 7.9%The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attributes this expansion to the rising prevalence and diagnosis of inflammatory bowel disease, increasing adoption of biologics for moderate-to-severe cases, and the continued introduction of therapies...0 Комментарии 0 Поделились 425 Просмотры 0 предпросмотр
-
Orthopedic Trauma Devices Market – Biologics Integration Enhancing Fracture Healing in High-Risk Nonunion PopulationsMarket Overview The orthopedic trauma devices market is increasingly integrating biologics such as bone morphogenetic proteins, platelet-rich plasma, and mesenchymal stem cell concentrates to enhance fracture healing in high-risk nonunion populations. Surgeons are combining biologics with fixation devices to address biological insufficiency in smokers, diabetics, and elderly patients with...0 Комментарии 0 Поделились 559 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
